SLDB Earnings Solid Biosciences Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–22 of 22
| Q2 2026 | 2026-06-30 | -0.88 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.52 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -1.99 | 2026-03-19 | 10-K |
| Q3 2025 | 2025-09-30 | -1.46 | 2025-11-03 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.98 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.59 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -3.06 | 2026-03-19 | 10-K |
| Q3 2025 | 2024-09-30 | -2.04 | 2025-11-03 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.25 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.64 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -4.83 | 2025-03-06 | 10-K |
| Q3 2024 | 2023-09-30 | -3.83 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.79 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.54 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -10.10 | 2024-03-13 | 10-K |
| Q3 2023 | 2022-09-30 | -9.42 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -6.71 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -3.37 | 2023-05-11 | 10-Q |
| FY 2023 | 2021-12-31 | -10.14 | 2024-03-13 | 10-K |
| Q3 2022 | 2021-09-30 | -7.68 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.35 | 2022-08-11 | 10-Q |
| FY 2022 | 2020-12-31 | -25.50 | 2023-03-23 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.